Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AI, Alex, Allurion, ANTEA, Authorisation, backed, Britain, compliant, cybersecurity, departure, detail, devise, dissatisfaction, downturn, East, Email, encumbered, England, enterprise, forty, gauge, GCP, GDPR, Great, hour, hypothecated, insolvency, Internet, linked, Live, Lou, Middle, misuse, Northern, Overview, PatentVest, peptide, pledged, possession, preservation, preserve, realign, restructuring, robust, Scotland, shrinkage, SI, side, stored, strictly, succeed, systemand, Taiwan, theft, thereunder, Thorton, timeframe, undergoing, uneconomical, unrest, unsuccessful, virtue, weak, weakened, York
Removed:
abandon, absenteeism, accreted, aid, amortized, approximating, attainment, attempt, banned, ceased, collateral, complementary, comprising, curtail, declared, deduction, depression, derive, deviate, dimensional, dispose, duration, eligibility, encompassing, exercised, expended, expiring, exported, extend, facilitate, final, forecasted, impairment, incomplete, incurring, inoperable, insufficiency, interruption, invention, Lender, limitation, liquidate, locally, magnitude, manufactured, Organisation, originally, originating, Paycheck, PPP, preclinical, prepare, prompted, proper, realized, recession, recommended, recover, Relief, repeat, replicate, Republic, SBA, spread, studying, taxable, typical, undertook, validate
Filing tables
Filing exhibits
Related press release
Associated NDRA transcripts
NDRA similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (File Nos. 333-235883, 333-233466, 333-254711, 333-277058) of our report dated March 28, 2024 on the consolidated financial statements of ENDRA Life Sciences Inc. and its subsidiaries, appearing in this Annual Report on Form 10-K of ENDRA Life Sciences Inc. for the year ended December 31, 2023. Our report includes an explanatory paragraph expressing substantial doubt regarding the Company’s ability to continue as a going concern.
/s/ RBSM LLP
New York, NY
March 28, 2024